Home Vaccination Strategies Against Highly Variable Pathogens by Lars Hangartner (Editor); Dennis R. Burton (Editor) (ISBN: 9783030580032)

Stock Photo: Cover May Be Different

Vaccination Strategies Against Highly Variable Pathogens Hardcover - 2020

Name: Vaccination Strategies Against Highly Variable Pathogens (Current Topics in Microbiology and Immunology, 428)
Price: 75.00 USD
Availability: InStock
ISBN: 9783030580032

by Lars Hangartner (Editor); Dennis R. Burton (Editor)

Browse more copies for sale ↓

From the rear cover

Vaccines against antigenically stable pathogens, or pathogens that only exist in a limited number of serotypes, have been very successful in the past and have drastically decreased the incidence and lethality of many diseases. However, when it comes to highly variable pathogens or viruses that exist in multiple serotypes, the traditional methods for vaccine development have reached their limits.
This volume highlights the development of vaccines against such challenging pathogens. Novel approaches for immunogen design, including structure-guided vaccine development and vaccines targeting glycans, as well as adjuvants and animal models used for testing possible vaccine candidates are outlined and discussed in detail. Given its scope, the book will appeal to scientists in the fields of infectious diseases, microbiology and medicine.

Details

Title Vaccination Strategies Against Highly Variable Pathogens
Author Lars Hangartner (Editor); Dennis R. Burton (Editor)
Binding Hardcover
Pages 180
Volumes 1
Language ENG
Publisher Springer
Date 2020-09-02
Illustrated Yes
Features Illustrated
ISBN 9783030580032 / 3030580032
Weight 0.98 lbs (0.44 kg)
Dimensions 9.21 x 6.14 x 0.5 in (23.39 x 15.60 x 1.27 cm)

About the author

Lars Hangartner, Ph.D.
Lars Hangartner is a molecular biologist and immunologist whose research focuses on the humoral response against variable pathogens, such as influenza A virus and HIV. Moreover, he has performed basic studies on measles virus and lymphocytic choriomeningitis virus. He is currently an associate professor at the Scripps Research Institute in La Jolla, California, and his present research investigates Fc/FcγR interactions as well as epitope mapping of polyclonal antibody response in the context of HIV vaccine development.
Dennis R. Burton, Ph.D.
Dennis Burton is the Chair and Professor in the Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA and James and Jessie Minor Chair in Immunology. He is the Scientific Director of the IAVI Neutralizing Antibody Center, Director of The Consortium for HIV/AIDS Vaccine Development (CHAVD) at Scripps, and a member of the Ragon Institute of MGH, MIT and Harvard, Boston, USA. His research is focused on infectious disease, in particular the interplay of antibodies and highly mutable viruses, notably HIV. He is interested in the potential of broadly neutralizing antibodies to inform vaccine design.